Cytek Biosciences, Inc. (CTKB) NASDAQ
4.53
+0.05(+1.12%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.53
+0.05(+1.12%)
Currency In USD
| Market Cap | 645.12M |
| Enterprise Value | 587.29M |
| P/E Ratio | -8.73 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 2.89 |
| Price/Book Ratio | 1.7 |
| Enterprise/Revenue | 2.6 |
| Enterprise/EBITDA | -32.9 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.33 |
| Operating Margin | -0.2 |
| Return On Assets | -0.14 |
| Return On Equity | -0.18 |
| Revenue | 201.49M |
| Revenue/Share | 1.57 |
| Gross Profit | 104.46M |
| EBITDA | -17.39M |
| Net Income | -66.54M |
| Diluted EPS | -0.52 |
| Total Cash | 261.53M |
| Total Cash/Share | 2.04 |
| Total Debt | 33.02M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 5.04 |
| Book Value Per Share | 2.67 |
| 52-Week Change | 21.77 |
| 52-Week High | 6.18 |
| 52-Week Low | 2.37 |
| Moving Average 50 Days | 4.54 |
| Moving Average 200 Days | 4.31 |
| Average Volume | 832,144 |
| Shares Outstanding | 128.55M |
| % Held by Institutions | 64.31 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |